Colorectal CancerNCT07024225
Colorectal Cancers :A Retrospective Study
An observational study of Colorectal Cancer, run by Sohag University at 1 site in Egypt.
Trial summary
Clinico-epidemiological and endoscopic characteristics of patients with colorectal cancers:A Retrospective study in Sohag The aim : 1. determine the prevalence and clinicopathological pattern of patients with colorectal cancers 2. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Colorectal Cancer
- What is being tested?
- Endoscope
- Type of treatment
- Surgery or procedure
- How many people
- 100 participants
- Where
- 1 siteEgypt
- Study dates
- 26 May 2025to 20 Dec 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Study will be carried on patients more than 18 diagnosed as colon or rectal cancer supported by histopathological result
Who may be able to join
- patients aged 18 years old and above
- patients with confirmed diagnosis of colon or rectal cancer ,supported by histopathological result
Who cannot join
- patients with missed pathological or endoscopic data
- patients diagnosed with other malignancies rather than colorectal cancers
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Sohag faculty of medicine
Sohag, Sohag Government
Khaled A Elsayed, Specialist, 01098540058, Drkhaled111aboeldahab@gmail.com
About this study
Official title: Clinico-epidemiological and Endoscopic Characteristics of Patients With Colorectal Cancers : A Retrospective Study in Sohag, Egypt
Clinico-epidemiological and endoscopic characteristics of patients with colorectal cancers:A Retrospective study in Sohag
The aim :
- determine the prevalence and clinicopathological pattern of patients with colorectal cancers
- interpretative association between risk factors and severity of patient condition to define possible predictors
- assess potential association between serum markers, imaging, endoscopic features and underlying condition.
Read the detailed description
Methods :
- all data will be obtained from patients as personal history (name, age, sex, occupation,residence , marital status, personal habits), history of illness at diagnosis, presence of diabetes or hypertension and other co-morbidity
- general examination as general appearance,vital signs ,head and neck ,chest ,upper and lower limbs, Abdomen and pelvis ,and local examination as per rectal examination.
- laboratory test as complete blood count and tumor markers ,imaging as abdominal ultrasound, CT,MRI, endoscopic findings and pathological features.
- Conditions
- Colorectal Cancer
- Being tested
- Endoscope
- Keywords
- Clinical, Endoscopic, Pathological features
- Medical subject headings
- Colorectal Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EndoscopeProcedure or surgery
Lower endoscopy
| Study group | Role | What they receive |
|---|---|---|
| Patients with colorectal cancers | Patients more than 18 years old with colorectal cancers Receives: Procedure: Endoscope |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number and proportion of patients diagnosed with colon or rectal cancers within study period in sohag, Egypt
To determine prevalence of colorectal cancers in sohag, Egypt
Measured: Retrospective review from 2015 to 2025
Correlation between baseline serum carcinoembryonic antigen (CEA) levels and tumor stage (TNM classification)
To assess the association between serum CEA levels and disease severity
Measured: As recorded at diagnosis
Association between personal risk factors (e.g, age, sex, lifestyle habits, comorbidities) and tumor stage at diagnosis
To identify risk factors associated with more advanced disease
Measured: based on initial diagnosis records from 2015 to 2025
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jun 2025
- Study start26 May 2025
- Primary completion20 Oct 2025 (estimated)
- Study completion20 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Colorectal CancerStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Khaled Abdelrahman Elsayed, Sohag University
- Investigators
- Ahmed O Ahmed, Lecturer, Study director, Sohag faculty of medicine, internal medicine department
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07024225
- Sponsor's protocol ID
- Soh-Med--25-5-8MS
- Status last verified
- Jun 2025
- First submitted
- 28 May 2025
- Last updated
- 17 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinico-epidemiological and Endoscopic Characteristics of Patients With Colorectal Cancers : A Retrospective Study in Sohag, Egypt
- ClinicalTrials.gov ID
- NCT07024225
- Acronym / sponsor ID
- Soh-Med--25-5-8MS
- Conditions
- Colorectal Cancer
- Keywords
- Clinical, Endoscopic, Pathological features
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 26 May 2025 (actual)
- Primary completion
- 20 Oct 2025 (estimated)
- Study completion
- 20 Dec 2025 (estimated)
- First posted
- 17 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Clinico-epidemiological and endoscopic characteristics of patients with colorectal cancers:A Retrospective study in Sohag
The aim :
- determine the prevalence and clinicopathological pattern of patients with colorectal cancers
- interpretative association between risk factors and severity of patient condition to define possible predictors
- assess potential association between serum markers, imaging, endoscopic features and underlying condition.
Detailed description
Methods :
- all data will be obtained from patients as personal history (name, age, sex, occupation,residence , marital status, personal habits), history of illness at diagnosis, presence of diabetes or hypertension and other co-morbidity
- general examination as general appearance,vital signs ,head and neck ,chest ,upper and lower limbs, Abdomen and pelvis ,and local examination as per rectal examination.
- laboratory test as complete blood count and tumor markers ,imaging as abdominal ultrasound, CT,MRI, endoscopic findings and pathological features.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients with colorectal cancers | – | Procedure: EndoscopePatients more than 18 years old with colorectal cancers |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Study will be carried on patients more than 18 diagnosed as colon or rectal cancer supported by histopathological result
Key inclusion criteria (2 listed)
- patients aged 18 years old and above
- patients with confirmed diagnosis of colon or rectal cancer ,supported by histopathological result
Key exclusion criteria (2 listed)
- patients with missed pathological or endoscopic data
- patients diagnosed with other malignancies rather than colorectal cancers
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EndoscopeLower endoscopy | Procedure or surgery | Patients with colorectal cancers |
Primary outcome
Number and proportion of patients diagnosed with colon or rectal cancers within study period in sohag, Egypt
Time frame: Retrospective review from 2015 to 2025
To determine prevalence of colorectal cancers in sohag, Egypt
Correlation between baseline serum carcinoembryonic antigen (CEA) levels and tumor stage (TNM classification)
Time frame: As recorded at diagnosis
To assess the association between serum CEA levels and disease severity
Association between personal risk factors (e.g, age, sex, lifestyle habits, comorbidities) and tumor stage at diagnosis
Time frame: based on initial diagnosis records from 2015 to 2025
To identify risk factors associated with more advanced disease
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jun 2025.
- Individual participant dataSharing planned: No
Related trials for Colorectal Cancer
RecruitingPhase 1/2
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma
Recruiting
Family Communications After Genetic Testing
Colon Adenocarcinoma, Colorectal Adenocarcinoma
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 3
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
Left-sided Colorectal Cancer
RecruitingPhase 1/2
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
Advanced NRAS-Mutant Melanoma, Advanced NRAS-Mutant Solid Tumors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ahmed O Ahmed, Lecturer study director
Sohag faculty of medicine, internal medicine department
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colorectal Cancer, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 17 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Khaled A Elsayed (01098540058, drkhaled111aboeldahab@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number and proportion of patients diagnosed with colon or rectal cancers within study period in sohag, Egypt (time frame: Retrospective review from 2015 to 2025). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2025.